These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16420965)

  • 21. Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells.
    Greco SJ; Sarkar S; Casadesus G; Zhu X; Smith MA; Ashford JW; Johnston JM; Tezapsidis N
    Neurosci Lett; 2009 May; 455(3):191-4. PubMed ID: 19429119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease.
    Farr SA; Ripley JL; Sultana R; Zhang Z; Niehoff ML; Platt TL; Murphy MP; Morley JE; Kumar V; Butterfield DA
    Free Radic Biol Med; 2014 Feb; 67():387-95. PubMed ID: 24355211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized Medicine and Resurrected Hopes for the Management of Alzheimer's Disease: A Modular Approach Based on GSK-3β Inhibitors.
    Arafa RK; Elghazawy NH
    Adv Exp Med Biol; 2017; 1007():199-224. PubMed ID: 28840559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β.
    Amin J; Paquet C; Baker A; Asuni AA; Love S; Holmes C; Hugon J; Nicoll JA; Boche D
    Neuropathol Appl Neurobiol; 2015 Jun; 41(4):445-57. PubMed ID: 25486988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
    Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation.
    Zhang YJ; Xu YF; Liu YH; Yin J; Wang JZ
    FEBS Lett; 2005 Nov; 579(27):6230-6. PubMed ID: 16253246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576.
    Chauhan NB; Siegel GJ; Feinstein DL
    Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta.
    Kitazawa M; Trinh DN; LaFerla FM
    Ann Neurol; 2008 Jul; 64(1):15-24. PubMed ID: 18318434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSK-3 is essential in the pathogenesis of Alzheimer's disease.
    Takashima A
    J Alzheimers Dis; 2006; 9(3 Suppl):309-17. PubMed ID: 16914869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.
    Björkdahl C; Sjögren MJ; Zhou X; Concha H; Avila J; Winblad B; Pei JJ
    J Neurosci Res; 2008 May; 86(6):1343-52. PubMed ID: 18061943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
    Selenica ML; Jensen HS; Larsen AK; Pedersen ML; Helboe L; Leist M; Lotharius J
    Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between glycogen synthase kinase-3beta genetic polymorphism and late-onset Alzheimer's disease.
    Mateo I; Infante J; Llorca J; Rodríguez E; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2006; 21(4):228-32. PubMed ID: 16428884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease.
    Bose A; Mouton-Liger F; Paquet C; Mazot P; Vigny M; Gray F; Hugon J
    Brain Pathol; 2011 Mar; 21(2):189-200. PubMed ID: 21029237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assays.
    Lin CH; Hsieh YS; Wu YR; Hsu CJ; Chen HC; Huang WH; Chang KH; Hsieh-Li HM; Su MT; Sun YC; Lee GC; Lee-Chen GJ
    Eur J Pharm Sci; 2016 Jun; 89():11-9. PubMed ID: 27094783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β.
    Wang XL; Zeng J; Yang Y; Xiong Y; Zhang ZH; Qiu M; Yan X; Sun XY; Tuo QZ; Liu R; Wang JZ
    J Alzheimers Dis; 2015; 43(1):153-65. PubMed ID: 25079798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells.
    Sato S; Tatebayashi Y; Akagi T; Chui DH; Murayama M; Miyasaka T; Planel E; Tanemura K; Sun X; Hashikawa T; Yoshioka K; Ishiguro K; Takashima A
    J Biol Chem; 2002 Nov; 277(44):42060-5. PubMed ID: 12191990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration.
    Engel T; Lucas JJ; Gómez-Ramos P; Moran MA; Avila J; Hernández F
    Neurobiol Aging; 2006 Sep; 27(9):1258-68. PubMed ID: 16054268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.